QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biotricity-announces-high-demand-for-its-lbiotres-pro-a-3-channel-patch-like-ecg-biotres-pro-is-expected-to-raise-the-average-subscription-price-by-over-32-translating-to-revenue-increase-of-up-to-10-from-sales-to-existing-customers-throughout-2025

Biotres Pro Is Also Capturing The Attention Of New Customers. The Initial Production Run Of Biotres Pro Has Sold Out, With Cust...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 biotricity-unveils-that-improved-margins-resulted-from-latest-advancements-to-its-proprietary-cardiac-ai-cloud-platform-and-announces-plans-for-continued-expansion-of-its-cardiac-ai-cloud

Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by th...

 biotricity-q3-2024-adj-eps-012-beats-044-estimate-sales-297m-miss-300m-estimate

Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.44) by...

 why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

 earnings-scheduled-for-february-20-2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

 biotricitys-earnings-outlook
Biotricity's Earnings Outlook
02/19/2024 20:01:46

 biotricity-expands-cardiac-ai-cloud-platform-development

Company's growing data ecosystem supports the development of large data models for its future predictive technologies and C...

 hc-wainwright--co-downgrades-biotricity-to-neutral

HC Wainwright & Co. analyst Kevin Dede downgrades Biotricity (NASDAQ:BTCY) from Buy to Neutral.

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 earnings-outlook-for-biotricity
Earnings Outlook For Biotricity
11/13/2023 18:02:00

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION